Kenya recalls Benylin cough syrup over safety concerns
Health & Science
By
Winfrey Owino
| Apr 11, 2024
The Pharmacy and Poisons Board (PPB) has directed outlets countrywide to stop the distribution of Benylin, a popular brand of children's cough syrup.
Benylin is a product of South African-based pharmaceutical company, Johnson and Johnson.
In a statement by Pharmacy Board, Chief Executive Fred Siyoi said the drug is under scrutiny over its safety and suitability for the Kenyan market.
The board says the decision was reached at after its Nigerian counterpart recalled the drug over safety issues.
READ MORE
Private developers eye deeper presence in Coast region
CS Kabogo: Digital economy now established, focus shifts to governance and accountability
How Ruto's aggression over fuel prices with EAC neighbours strains ties
Ruto opts for electric cars to escape high fuel prices
Kenya, Netherlands moot corridor to link EAC and Europe
Coastal property developers bank on Badawy to spearhead expansion strategy
Kenya to host Africa's digital economy summit as push for unified market intensifies
Afreximbank launches third AfCFTA bootcamp, firms urged to tap trade pact
Africa urged to plug leakages, mobilise local capital as global funding dries up